• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

EID: Highly Pathogenic Avian Influenza A(H5N1) from Wild Birds, Poultry, and Mammals, Peru

Shiloh

Editor, Senior Moderator
Source: https://wwwnc.cdc.gov/eid/article/29/12/23-0505_article

Volume 29, Number 12—December 2023
Research Letter
Highly Pathogenic Avian Influenza A(H5N1) from Wild Birds, Poultry, and Mammals, Peru

Cristopher D. Cruz, M. Eliana Icochea, Victoria Espejo, Gilda Troncos, Gina R. Castro-Sanguinetti, Megan A. Schilling, and Yeny TinocoComments to Author
Author affiliations: US Naval Medical Research Unit SOUTH, Lima, Peru (C.D. Cruz, V. Espejo, G. Troncos, M.A. Schilling, Y. Tinoco); Universidad Nacional Mayor de San Marcos, Lima (M.E. Icochea, G.R. Castro-Sanguinetti)


Abstract

We identified highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b in wild birds, poultry, and a lion in Peru during November 2022–February 2023 and markers associated with transmission adaptation and antiviral drug resistance. Continuous genomic surveillance is needed to inform public health measures and avoid mass animal deaths.

 
Back
Top Bottom